Therapeutics: Src; v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1)

Cancer

INDICATION: Cancer

In vitro, zebrafish and mouse studies identified a selective pyrazolopyrimidine-based Src inhibitor that could help treat cancer. Chemical synthesis and in vitro testing

Read the full 245 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE